Aarti Drugs Ltd

₹429.05▼ -0.16%28 Sept

📊 Stock Analysis

Market Data

Market Cap₹3,915.94 Cr.

52W High₹533.6

Current Price₹429.05

52W Low₹318.6

Down from 52W High19.6 %

Face Value₹10

Performance

ROCE12.39 %

ROE12.34 %

EPS (TTM)₹5.49

EPS Prev Qtr₹6.05

EPS Last Year₹4.95

EBITDA Qtr₹79.74 Cr.

Book Value₹170

Financial Health

Debt/Equity0.37

Debt/Profit3.02

Total Assets₹2,815.26 Cr.

Dividend Yield0.47 %

Promoter Holding54.43 %

Earning Power9.33 %

Valuation

Stock P/E20.5

Industry P/E33.81

Price to Book2.53

Price to Sales1.46

Graham Number₹282.6

Key Metrics

Face Value

₹10

About Aarti Drugs Ltd

Healthcare · Pharmaceuticals

Aarti Drugs Ltd is listed on NSE in the Healthcare / Pharmaceuticals sector. Face value ₹10. Market cap ₹3,915.94 Cr.

Price Chart

Peer Comparison

Name	CMP	P/E	Market Cap	Div Yield	NP Qtr	Qtr Profit Var%	Sales Qtr	Qtr Sales Var%	ROCE%	Debt/Eq
Sun Pharmaceutical Industries Ltd	-	36.51	₹4,41,477.63 Cr	0.87%	₹12,172.7 Cr	-	₹59,910.52 Cr	-	18.72%	0.05
Divis Laboratories Ltd	-	86.48	₹2,53,031.38 Cr	0.31%	₹2,925 Cr	-	₹11,230 Cr	-	23.04%	0
Torrent Pharmaceuticals Ltd	-	77.67	₹1,85,216.32 Cr	0.78%	₹2,156 Cr	-	₹15,723 Cr	-	15.1%	1.76
Zydus Lifesciences Ltd	-	27.01	₹1,20,897.46 Cr	0.08%	₹4,492.2 Cr	-	₹28,591.7 Cr	-	16.76%	0.43
Cipla Ltd	-	33.28	₹1,12,201.64 Cr	0.94%	₹3,364.84 Cr	-	₹28,324.4 Cr	-	13.24%	0.01
Laurus Labs Ltd	-	99.31	₹1,08,698.22 Cr	0.06%	₹1,090.76 Cr	-	₹7,269.64 Cr	-	20.79%	0.45
Dr Reddys Laboratories Ltd	-	31.6	₹1,02,039.12 Cr	0.65%	₹3,183.3 Cr	-	₹33,227.9 Cr	-	10.05%	0.17
Mankind Pharma Ltd	-	49.29	₹1,00,752.43 Cr	0.04%	₹2,067.57 Cr	-	₹14,737.88 Cr	-	13.95%	0.38
Aurobindo Pharma Ltd	-	26.56	₹97,814.24 Cr	0.24%	₹3,710.8 Cr	-	₹34,935.29 Cr	-	12.75%	0.2
Lupin Ltd	-	16.64	₹94,274.49 Cr	0.87%	₹5,550.99 Cr	-	₹29,966.58 Cr	-	27.95%	0.26
Glenmark Pharmaceuticals Ltd	-	36.67	₹65,922.11 Cr	0.11%	₹1,797.81 Cr	-	₹17,736.56 Cr	-	24.78%	0.25
Alkem Laboratories Ltd	-	28.65	₹61,804.34 Cr	1.03%	₹2,206.3 Cr	-	₹15,081.28 Cr	-	19.75%	0.12
Biocon Ltd	-	110.29	₹61,113.53 Cr	0.13%	₹416.4 Cr	-	₹17,321.1 Cr	-	2.87%	0.43
Abbott India Ltd	-	35.22	₹56,860.69 Cr	1.78%	₹1,614.68 Cr	-	₹7,004.38 Cr	-	45.73%	0
Glaxosmithkline Pharmaceuticals Ltd	-	46.73	₹49,091.33 Cr	1.97%	₹1,068.15 Cr	-	₹3,954.94 Cr	-	64.07%	0
Ipca Laboratories Ltd	-	36.13	₹48,712.48 Cr	0.31%	₹1,379.76 Cr	-	₹10,125.58 Cr	-	21.48%	0.09
Anthem Biosciences Ltd	-	83.03	₹47,949.68 Cr	0.23%	₹575.95 Cr	-	₹2,002.34 Cr	-	25.5%	0.02
Gland Pharma Ltd	-	42.26	₹47,764.08 Cr	0.69%	₹1,128.8 Cr	-	₹6,725.3 Cr	-	15.21%	0.02
Ajanta Pharma Ltd	-	38.87	₹44,109.77 Cr	0.79%	₹1,134.88 Cr	-	₹5,776.17 Cr	-	31.81%	0.05
J B Chemicals & Pharmaceuticals Ltd	-	53.3	₹38,730.77 Cr	0.39%	₹709.46 Cr	-	₹4,147.79 Cr	-	23.03%	0

Quarterly Results

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	652.79	601.71	720.3	702.78
↳ QoQ Growth	-	-7.8%	+19.7%	-2.4%
Expenses	584.77	564.63	642.54	623.04
Operating Profit	68.02	37.08	77.76	79.74
OPM %	10.42%	6.16%	10.8%	11.35%
Other Income	0.09	1.23	0.76	0.81
Interest	7.7	9.29	8.16	9.22
Depreciation	16.26	17.95	18.04	18.46
EBITDA	84.28	55.03	95.8	98.2
EBITDA Margin %	12.91%	9.15%	13.3%	13.97%
Profit Before Tax	60.41	29.02	70.36	69.24
Tax %	25.24%	-39.73%	21.46%	27.6%
Net Profit	45.16	40.55	55.26	50.13
↳ QoQ Growth	-	-10.2%	+36.3%	-9.3%
EPS	4.95	4.44	6.05	5.49

Balance Sheet

	Mar 2025	Mar 2026
Equity Capital	91.27	91.27
Reserves	1277.7285	1457.59
Borrowings	612.24	576.64
Other Liabilities	593.44	689.76
Total Liabilities	2574.6782	2815.26
Fixed Assets	922.1455	1069.97
CWIP	274.1457	213.81
Investments	22.41	27.31
Other Assets	1355.98	1504.17
Total Assets	2574.6782	2815.26

Cash Flows

	Mar 2025
Cash from Operating Activity	244.5838
Cash from Investing Activity	-164.6308
Cash from Financing Activity	-82.1185
Net Cash Flow	-2.1655

Shareholding Pattern

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters %	54.72%	55.03%	55.03%	54.43%
FIIs %	2.69%	2.15%	1.58%	1.52%
DIIs %	9.9%	10.12%	10.22%	10.29%
Public %	23.58%	23.43%	23.72%	24.12%
No. of Shareholders	1,52,252	1,48,363	1,44,946	1,43,476